Suppr超能文献

程序性细胞死亡蛋白1配体1的表达机制及其在间充质干细胞免疫调节能力中的作用。

The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells.

作者信息

Chen Zhuo, Yao Meng-Wei, Ao Xiang, Gong Qing-Jia, Yang Yi, Liu Jin-Xia, Lian Qi-Zhou, Xu Xiang, Zuo Ling-Jing

机构信息

Department of Stem Cell & Regenerative Medicine, State Key Laboratory of Trauma, Burn and Combined Injury, Daping Hospital, Army Medical University, Chongqing, 400042, China; College of Basic Medical Sciences, Army Medical University, Chongqing, 400038, China.

Department of Stem Cell & Regenerative Medicine, State Key Laboratory of Trauma, Burn and Combined Injury, Daping Hospital, Army Medical University, Chongqing, 400042, China.

出版信息

Chin J Traumatol. 2024 Jan;27(1):1-10. doi: 10.1016/j.cjtee.2023.11.003. Epub 2023 Nov 23.

Abstract

Programmed cell death 1 ligand 1 (PD-L1) is an important immunosuppressive molecule, which inhibits the function of T cells and other immune cells by binding to the receptor programmed cell death-1. The PD-L1 expression disorder plays an important role in the occurrence, development, and treatment of sepsis or other inflammatory diseases, and has become an important target for the treatment of these diseases. Mesenchymal stem cells (MSCs) are a kind of pluripotent stem cells with multiple differentiation potential. In recent years, MSCs have been found to have a strong immunosuppressive ability and are used to treat various inflammatory insults caused by hyperimmune diseases. Moreover, PD-L1 is deeply involved in the immunosuppressive events of MSCs and plays an important role in the treatment of various diseases. In this review, we will summarize the main regulatory mechanism of PD-L1 expression, and discuss various biological functions of PD-L1 in the immune regulation of MSCs.

摘要

程序性细胞死亡1配体1(PD-L1)是一种重要的免疫抑制分子,它通过与程序性细胞死亡受体1结合来抑制T细胞和其他免疫细胞的功能。PD-L1表达紊乱在脓毒症或其他炎症性疾病的发生、发展及治疗中起重要作用,已成为这些疾病治疗的重要靶点。间充质干细胞(MSCs)是一类具有多向分化潜能的多能干细胞。近年来,发现MSCs具有强大的免疫抑制能力,并被用于治疗由超免疫疾病引起的各种炎症损伤。此外,PD-L1深度参与MSCs的免疫抑制事件,并在各种疾病的治疗中发挥重要作用。在本综述中,我们将总结PD-L1表达的主要调控机制,并讨论PD-L1在MSCs免疫调节中的各种生物学功能。

相似文献

1
The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells.
Chin J Traumatol. 2024 Jan;27(1):1-10. doi: 10.1016/j.cjtee.2023.11.003. Epub 2023 Nov 23.
4
N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cells.
Stem Cells. 2020 Aug;38(8):986-993. doi: 10.1002/stem.3190. Epub 2020 May 12.
5
Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice.
Curr Stem Cell Res Ther. 2022;17(6):564-575. doi: 10.2174/1574888X17666220127110332.
6
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.
Stem Cells. 2017 Mar;35(3):766-776. doi: 10.1002/stem.2509. Epub 2016 Oct 26.
7
Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
Diabetologia. 2022 Jul;65(7):1185-1197. doi: 10.1007/s00125-022-05708-3. Epub 2022 May 5.
9
WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1.
J Extracell Vesicles. 2021 Feb;10(4):e12067. doi: 10.1002/jev2.12067. Epub 2021 Feb 8.

本文引用的文献

1
Role of regulation of PD-1 and PD-L1 expression in sepsis.
Front Immunol. 2023 Mar 9;14:1029438. doi: 10.3389/fimmu.2023.1029438. eCollection 2023.
2
Fibroblast-like cells Promote Wound Healing via PD-L1-mediated Inflammation Resolution.
Int J Biol Sci. 2022 Jul 4;18(11):4388-4399. doi: 10.7150/ijbs.69890. eCollection 2022.
4
Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice.
Curr Stem Cell Res Ther. 2022;17(6):564-575. doi: 10.2174/1574888X17666220127110332.
6
eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.
BMC Cancer. 2021 Sep 15;21(1):1022. doi: 10.1186/s12885-021-08749-w.
7
TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity.
Nat Commun. 2021 Sep 13;12(1):5405. doi: 10.1038/s41467-021-25662-9.
8
Programmed Cell Death Ligand 1-Transfected Mouse Bone Marrow Mesenchymal Stem Cells as Targeted Therapy for Rheumatoid Arthritis.
Biomed Res Int. 2021 Aug 30;2021:5574282. doi: 10.1155/2021/5574282. eCollection 2021.
9
The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.
Front Immunol. 2021 Aug 16;12:686356. doi: 10.3389/fimmu.2021.686356. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验